Duration of Antibiotic Use Among Adults With Uncomplicated Community-Acquired Pneumonia Requiring Hospitalization in the United States | Zendy

Sarah H. Yi | Zendy; Kelly M Hatfield | Zendy; James Baggs | Zendy; Lauri A. Hicks | Zendy; Arjun Srinivasan | Zendy; Sujan Reddy | Zendy; John A. Jernigan | Zendy

Open Access

Duration of Antibiotic Use Among Adults With Uncomplicated Community-Acquired Pneumonia Requiring Hospitalization in the United States

Author(s) -

Sarah H. Yi,

Kelly M Hatfield,

James Baggs,

Lauri A. Hicks,

Arjun Srinivasan,

Sujan Reddy,

John A. Jernigan

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix986

Subject(s) - medicine , quartile , antimicrobial stewardship , pneumonia , medical prescription , pharmacy , retrospective cohort study , community acquired pneumonia , emergency medicine , pediatrics , antibiotics , confidence interval , family medicine , antibiotic resistance , microbiology and biotechnology , pharmacology , biology

Previous studies suggest that duration of antibiotic therapy for community-acquired pneumonia (CAP) often exceeds national recommendations and might represent an important opportunity to improve antibiotic stewardship nationally. Our objective was to determine the average length of antibiotic therapy (LOT) for patients treated for uncomplicated CAP in US hospitals and the proportion of patients with excessive durations.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research